Prosight Management, LP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,508,794
-34.1%
299,022
-22.0%
0.38%
-79.2%
Q1 2023$3,807,629
-36.3%
383,447
-55.3%
1.80%
-44.6%
Q4 2022$5,976,615
-7.6%
858,709
-29.1%
3.26%
-5.9%
Q3 2022$6,466,000
-18.4%
1,210,800
-39.0%
3.46%
-44.5%
Q2 2022$7,924,000
+27.3%
1,985,883
+41.8%
6.24%
+55.4%
Q1 2022$6,224,000
+34.7%
1,400,239
+21.2%
4.02%
+45.3%
Q4 2021$4,621,000
-28.4%
1,155,300
+57.2%
2.77%
-22.1%
Q3 2021$6,453,000
-4.3%
735,000
+23.5%
3.55%
-15.8%
Q2 2021$6,744,000
+19.9%
595,239
+25.7%
4.22%
-8.4%
Q1 2021$5,625,000
-9.7%
473,446
-47.9%
4.61%
+60.0%
Q4 2020$6,232,000
-23.0%
908,488
-16.8%
2.88%
-25.2%
Q3 2020$8,092,000
+19.8%
1,092,000
-32.6%
3.85%
+32.7%
Q2 2020$6,756,000
+34.4%
1,620,200
-20.4%
2.90%
+23.4%
Q1 2020$5,027,000
-39.4%
2,035,340
+42.5%
2.35%
-35.5%
Q4 2019$8,298,000
+99.2%
1,428,277
+80.7%
3.64%
+57.7%
Q3 2019$4,165,000
-0.5%
790,228
+13.2%
2.31%
+9.4%
Q2 2019$4,188,000
-20.5%
697,921
+19.7%
2.11%
-8.3%
Q1 2019$5,267,000
+56.9%
583,300
+44.2%
2.30%
+32.9%
Q4 2018$3,357,000404,4631.73%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders